» Articles » PMID: 10713003

Breath Carbon Monoxide As an Indication of Smoking Habit

Overview
Journal Chest
Publisher Elsevier
Specialty Pulmonary Medicine
Date 2000 Mar 14
PMID 10713003
Citations 143
Authors
Affiliations
Soon will be listed here.
Abstract

Study Objective: To assess whether the breath carbon monoxide (CO) concentration can be used to determine a patient's smoking habits in a respiratory outpatient clinic.

Design: To provide a normal range for smokers and nonsmokers, 41 outpatients and 24 healthy subjects were questioned on their smoking habits and asked to provide two breaths into a CO monitor (EC50 Smokerlyser; Bedfont Instruments; Kent, UK). In a subsequent single-blind study, 51 different outpatients were not told of the purpose of the study and were assessed by extensive questionnaire, spirometry, and Smokerlyser estimation.

Setting: The Chest Clinic and Pulmonary Medicine Department at the Northern General Hospital, Sheffield, UK.

Participants: Phase 1 involved 41 outpatients attending the Chest Clinic and 24 nonoutpatient colleagues. In phase 2, an additional 51 different outpatients were studied.

Measurements And Results: The mean (SD) breath CO levels were 17.4 (11.6) parts per million (ppm) for smokers and 1.8 (1.3) ppm for nonsmokers (p < 0.001). A level of 6 ppm was taken as the cutoff, as this gave a selectivity of 96% and a sensitivity of 94% for outpatients. Of the 51 study patients, 5 admitted to smoking in the administered questionnaire. Eight denied smoking but had a mean breath CO > 6 ppm (7.5 to 42 ppm). Of these, three admitted to smoking after being explained the implication of the reading.

Conclusions: Breath CO concentration provides an easy, noninvasive, and immediate way of assessing a patient's smoking status. A reading > 6 ppm strongly suggests that an outpatient is a smoker.

Citing Articles

Adherence to a digital therapeutic mediates the relationship between momentary self-regulation and health risk behaviors.

Plaitano E, McNeish D, Bartels S, Bell K, Dallery J, Grabinski M Front Digit Health. 2025; 7:1467772.

PMID: 39981105 PMC: 11841403. DOI: 10.3389/fdgth.2025.1467772.


Exhaled Breath Analysis: From Laboratory Test to Wearable Sensing.

Heng W, Yin S, Chen Y, Gao W IEEE Rev Biomed Eng. 2024; 18:50-73.

PMID: 39412981 PMC: 11875904. DOI: 10.1109/RBME.2024.3481360.


Safety and efficacy of CyTisine for smoking cessation in a hOSPital context (CITOSP): study protocol for a prospective observational study.

Torazzi A, Tedesco E, Ceccato S, Santin L, Campagnari S, Losso L Front Public Health. 2024; 12:1350176.

PMID: 39403432 PMC: 11471529. DOI: 10.3389/fpubh.2024.1350176.


Self-reported smoking status and exhaled carbon monoxide in secondary preventive follow-up after coronary heart events: Do our patients tell the truth?.

Kaldal A, Tonstad S, Jortveit J Tob Prev Cessat. 2024; 10.

PMID: 39323439 PMC: 11423699. DOI: 10.18332/tpc/191843.


Multimodal smoking cessation treatment combining repetitive transcranial magnetic stimulation, cognitive behavioral therapy, and nicotine replacement in veterans with posttraumatic stress disorder: A feasibility randomized controlled trial protocol.

Young J, Polick C, Michael A, Dannhauer M, Galla J, Evans M PLoS One. 2024; 19(9):e0291562.

PMID: 39240791 PMC: 11379281. DOI: 10.1371/journal.pone.0291562.